These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 28449010)
1. Excess of a Rassf1-targeting microRNA, miR-193a-3p, perturbs cell division fidelity. Pruikkonen S; Kallio MJ Br J Cancer; 2017 May; 116(11):1451-1461. PubMed ID: 28449010 [TBL] [Abstract][Full Text] [Related]
2. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2. Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181 [TBL] [Abstract][Full Text] [Related]
3. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis-Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD. Pekow J; Meckel K; Dougherty U; Huang Y; Chen X; Almoghrabi A; Mustafi R; Ayaloglu-Butun F; Deng Z; Haider HI; Hart J; Rubin DT; Kwon JH; Bissonnette M Clin Cancer Res; 2017 Sep; 23(17):5281-5291. PubMed ID: 28600480 [No Abstract] [Full Text] [Related]
5. Methylation-associated silencing of Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818 [TBL] [Abstract][Full Text] [Related]
6. microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer. Takahashi H; Takahashi M; Ohnuma S; Unno M; Yoshino Y; Ouchi K; Takahashi S; Yamada Y; Shimodaira H; Ishioka C BMC Cancer; 2017 Nov; 17(1):723. PubMed ID: 29115941 [TBL] [Abstract][Full Text] [Related]
7. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
8. Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p. Seviour EG; Sehgal V; Mishra D; Rupaimoole R; Rodriguez-Aguayo C; Lopez-Berestein G; Lee JS; Sood AK; Kim MP; Mills GB; Ram PT Oncogene; 2017 Mar; 36(10):1339-1350. PubMed ID: 27669434 [TBL] [Abstract][Full Text] [Related]
9. Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells. Lee SD; Yu D; Lee DY; Shin HS; Jo JH; Lee YC Cancer Sci; 2019 Feb; 110(2):662-673. PubMed ID: 30485589 [TBL] [Abstract][Full Text] [Related]
10. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4. Liang H; Liu M; Yan X; Zhou Y; Wang W; Wang X; Fu Z; Wang N; Zhang S; Wang Y; Zen K; Zhang CY; Hou D; Li J; Chen X J Biol Chem; 2015 Jan; 290(2):926-40. PubMed ID: 25391651 [TBL] [Abstract][Full Text] [Related]
11. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer. Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308 [TBL] [Abstract][Full Text] [Related]
13. Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma. Polini B; Carpi S; Doccini S; Citi V; Martelli A; Feola S; Santorelli FM; Cerullo V; Romanini A; Nieri P Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867069 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis. Mamoori A; Wahab R; Islam F; Lee K; Vider J; Lu CT; Gopalan V; Lam AK Hum Pathol; 2018 Jan; 71():145-156. PubMed ID: 29104111 [TBL] [Abstract][Full Text] [Related]
15. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789 [TBL] [Abstract][Full Text] [Related]
16. MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells. Huang B; Luo W; Sun L; Zhang Q; Jiang L; Chang J; Qiu X; Wang E Int J Oncol; 2013 May; 42(5):1734-42. PubMed ID: 23525486 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-126-3p suppresses cell proliferation by targeting PIK3R2 in Kaposi's sarcoma cells. Wu XJ; Zhao ZF; Kang XJ; Wang HJ; Zhao J; Pu XM Oncotarget; 2016 Jun; 7(24):36614-36621. PubMed ID: 27191494 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1. Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705 [TBL] [Abstract][Full Text] [Related]
19. Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Nakano H; Yamada Y; Miyazawa T; Yoshida T Int J Oncol; 2013 Jun; 42(6):1875-82. PubMed ID: 23588298 [TBL] [Abstract][Full Text] [Related]
20. miR-193a-3p Promotes Radio-Resistance of Nasopharyngeal Cancer Cells by Targeting SRSF2 Gene and Hypoxia Signaling Pathway. Kong L; Wei Q; Hu X; Chen L; Li J Med Sci Monit Basic Res; 2019 Feb; 25():53-62. PubMed ID: 30773530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]